Cerebrovascular Reserve Testing
Learn how NeuraSignal’s advanced Transcranial Doppler (TCD) technology measures cerebrovascular reserve (CVR) to assess brain hemodynamic health, stratify stroke risk, and support clinical decision-making in neurological conditions.
What is Cerebrovascular Reserve (CVR)?
Cerebrovascular reserve (also called cerebral vasomotor reactivity) refers to the brain’s ability to increase cerebral blood flow (CBF) in response to a vasodilatory stimulus. It reflects the capacity of cerebral arterioles to dilate beyond their resting state, serving as a critical indicator of the brain’s hemodynamic health and its ability to compensate for changes in perfusion pressure. 1 2
Why Measure CVR with TCD?
Transcranial Doppler ultrasonography is a non-invasive, real-time, bedside-capable method for assessing cerebrovascular reserve by measuring changes in cerebral blood flow velocity (CBFV) in the middle cerebral artery (MCA) and other intracranial vessels before and after a vasodilatory challenge. 3 4
Key advantages include:
Clinical Applications
Impaired CVR in patients with carotid artery stenosis or occlusion is a strong independent predictor of future ischemic stroke. Markus & Cullinane (2001) demonstrated that exhausted MCA reactivity predicted ipsilateral stroke and TIA risk with an odds ratio of 14.4 (95% CI 2.63–78.74, p=0.0021). 5 A meta-analysis of 754 patients by Reinhard et al. (2014) confirmed impaired CO₂ reactivity was independently associated with increased stroke risk (HR 3.69; CI 2.01–6.77; p<0.0001). 6
CVR assessment helps determine the hemodynamic significance of carotid stenosis beyond anatomical grading, identifying patients with exhausted vasodilatory capacity who are at greatest risk. Silvestrini et al. (2000) showed impaired vasoreactivity was associated with increased stroke risk in asymptomatic carotid stenosis. 8 Vernieri et al. (2001) demonstrated that collateral blood flow and CVR together predicted outcomes in carotid artery occlusion. 9
Monitoring CVR helps detect vasospasm and assess the risk of delayed cerebral ischemia. Szabo et al. (1997) used TCD with acetazolamide testing to evaluate cerebrovascular reserve capacity years after aneurysmal SAH with vasospasm. 10
Impaired CVR has been associated with white matter hyperintensities, cognitive decline, and increased risk of vascular dementia. Fisicaro et al. (2022) demonstrated subtle CVR changes detectable by TCD even in conditions like celiac disease, correlating with cognitive scores. 7
Serial CVR monitoring guides surgical decision-making and evaluates the effectiveness of revascularization procedures. 1 3
CVR testing can reveal impaired autoregulation and microvascular dysfunction following TBI, aiding in prognosis and management. 3
Testing Methods
Breath-Holding Index (BHI): 11 12
The patient holds their breath for ~30 seconds, inducing hypercapnia. The BHI is calculated as the percentage increase in MCA flow velocity divided by the breath-hold duration. A BHI < 0.69 is generally considered impaired.
CO₂ Inhalation Challenge: 2 5
Inhalation of 5–8% CO₂ provides a more standardized stimulus. The change in CBFV per mmHg change in end-tidal CO₂ (EtCO₂) quantifies vasomotor reactivity. Markus & Cullinane used 8% CO₂ and found it slightly more effective than 6% CO₂ for predicting stroke risk. 5
Acetazolamide (Diamox) Challenge: 1 10
IV administration of acetazolamide (1g) induces maximal vasodilation. CBFV is measured before and after administration. A <20% increase or asymmetry >10% suggests impaired reserve. Piepgras et al. (1990) developed this as a simple bedside test using TCD. 1
Book a Live Demo
Let's Get started
Discover the future of automated Transcranial Doppler technology. Schedule a brief demo with our specialists to see how non-invasive, robotic TCD fits into your hospital’s workflow.
With real-time information, clinical teams can make more informed decisions about patient management, leading to reduced length of stay and improving patient outcomes.
With the NeuraSignal Platform, healthcare professionals can detect and manage complications more quickly, helping to prevent adverse outcomes, reduce hospital readmissions, and ultimately leading to better patient satisfaction.
References
- Piepgras A, Schmiedek P, Leinsinger G, et al. “A simple test to assess cerebrovascular reserve capacity using transcranial Doppler sonography and acetazolamide.” Stroke. 1990;21(9):1306–1311.
- Ringelstein EB, Sievers C, Ecker S, et al. “Noninvasive assessment of CO2-induced cerebral vasomotor response in normal individuals and patients with internal carotid artery occlusions.” Stroke. 1988;19(8):963–969.
- Pan Y, Wan W, Xiang M, Guan Y. “Transcranial Doppler Ultrasonography as a Diagnostic Tool for Cerebrovascular Disorders.” Front. Hum. Neurosci. 2022;16:841809.
- Russo G, Lodi C, Ursino M. “Quantitative assessment of cerebral vascular reserve by means of transcranial Doppler ultrasound and rebreathing maneuver.” Neurol Sci. 2000;21:292–302.
- Markus H, Cullinane M. “Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion.” Brain. 2001;124(3):457–467.
- Reinhard M, Schwarzer G, Briel M, et al. “Cerebrovascular reactivity predicts stroke in high-grade carotid artery disease.” Neurology. 2014;83(16):1424–1431.
- Fisicaro F, Lanza G, D’Agate CC, et al. “Cerebral hemodynamic changes to transcranial Doppler sonography in celiac disease: A pilot study.” Front. Hum. Neurosci. 2022;16:931727.
- Silvestrini M, Vernieri F, Pasqualetti P, et al. “Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis.” JAMA. 2000;283(16):2122–2127.
- Vernieri F, Pasqualetti P, Matteis M, et al. “Effect of collateral blood flow and cerebral vasomotor reactivity on the outcome of carotid artery occlusion.” Stroke. 2001;32(7):1552–1558.
- Szabo S, Sheth RN, Novak L, et al. “Cerebrovascular reserve capacity many years after vasospasm due to aneurysmal subarachnoid hemorrhage.” Stroke. 1997;28(12):2479–2482.
- Müller M, Voges M, Piepgras U, Schimrigk K. “Assessment of cerebral vasomotor reactivity by transcranial Doppler ultrasound and breath-holding.” Stroke. 1995;26(1):96–100.
- Barrett KM, Ackerman RH, Gahn G, et al. “Basilar and middle cerebral artery reserve: a comparative study using transcranial Doppler and breath-holding techniques.” Stroke. 2001;32(12):2793–2796.
Disclaimer of Information & Content
The information provided on the NeuraSignal website is intended for educational and informational purposes only and should not be construed as medical advice, a diagnostic opinion, or a guarantee of clinical outcome. While NeuraSignal strives to present accurate and up-to-date information sourced from peer-reviewed literature and reputable clinical references, NeuraSignal makes no representations or warranties regarding the completeness, accuracy, reliability, or timeliness of any content presented herein. No individual, including patients currently under clinical evaluation, should rely on the information, tools, or resources available on this website for self-diagnosis, self-treatment, or as a substitute for professional medical consultation. Clinical decisions should always be made in partnership with a qualified healthcare provider. NeuraSignal expressly disclaims any liability arising from the use or interpretation of the content on this website.